However, when anti-CD73 mAb or anti-PD-1 mAb or the combination of antibodies was administered 3 days following the last intrathecal (i.t.)reovirus treatment, combining treatments (reovirus plus antibody) significantly prolonged the tumor control of the mice beyond that observed with reovirus alone. Here, PDCD1 is linked to neoplasm.